Source

Format

License

32569 results

A 14-Month Open-Label Extension Phase of the Double-Blind Placebo-Controlled Dose-Escalation Parallel-Group Study of E2007 as an Adjunctive Therapy in Patients With Refractory Partial Seizures revised per Amendments 02 and 03

json

json

A phase II trial in patients with myelofibrosis primary post-ET or post PV-MF treated with the selective JAK2 inhibitor Pacritinib before reduced-intensity conditioning allogeneic stem cell transplantation

A phase II trial in patients with myelofibrosis primary post-ET or post PV-MF treated with the selective JAK2 inhibitor Pacritinib before reduced-intensity conditioning allogeneic stem cell transplantation
json

A PHASE 2B MULTICENTER RANDOMIZED DOUBLE-BLIND COMPARATIVE TRIAL OF UK-453061 IN COMBINATION WITH TENOFOVIR DF AND EMTRICITABINE VERSUS EFAVIRENZ IN COMBINATION WITH TENOFOVIR DF AND EMTRICITABINE FOR THE TREATMENT OF ANTIRETROVIRAL-NAIVE HIV-1 INFECTED SUBJECTS

json

An Open-Label Prospective Randomized Controlled Multi-Center Study Assessing Fixed Dose Vs Concentration Controlled Cellcept Regimens For Patients Following A Single Organ Renal Transplantation In Combination With Full Dose And Reduced Dose Calcineurin Inhibitors

Study of Therapeutic Monitoring of CellCept Mycophenolate Mofetil After Kidney Transplantation
json